Trial · NCT01611571
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fracture, patella | Injury, poisoning and procedural complications | Active Risedronate Active Teriparatide | 1 | 10 | 1 |
| other | Fracture, patella | Injury, poisoning and procedural complications | Active Risedronte Placebo Teriparatide | 0 | 10 | 0 |
| other | Fracture, patella | Injury, poisoning and procedural complications | Placebo Risedronate Active Teriparatide, Active Risedronate | 0 | 9 | 0 |
| other | Fracture, vertebral | Endocrine disorders | Active Risedronate Active Teriparatide | 1 | 10 | 1 |
| other | Fracture, vertebral | Endocrine disorders | Active Risedronte Placebo Teriparatide | 1 | 10 | 1 |
| other | Fracture, vertebral | Endocrine disorders | Placebo Risedronate Active Teriparatide, Active Risedronate | 0 | 9 | 0 |
| other | Fatigue | Endocrine disorders | Active Risedronate Active Teriparatide | 0 | 10 | 0 |
| other | Fatigue | Endocrine disorders | Active Risedronte Placebo Teriparatide | 1 | 10 | 1 |
| other | Fatigue | Endocrine disorders | Placebo Risedronate Active Teriparatide, Active Risedronate | 0 | 9 | 0 |
| other | Gastroesophageal Reflux | Gastrointestinal disorders | Active Risedronate Active Teriparatide | 1 | 10 | 4 |
| other | Gastroesophageal Reflux | Gastrointestinal disorders | Active Risedronte Placebo Teriparatide | 1 | 10 | 3 |
| other | Gastroesophageal Reflux | Gastrointestinal disorders | Placebo Risedronate Active Teriparatide, Active Risedronate | 0 | 9 | 0 |
| other | Injection Site Irritation | Skin and subcutaneous tissue disorders | Active Risedronate Active Teriparatide | 2 | 10 | 4 |
| other | Injection Site Irritation | Skin and subcutaneous tissue disorders | Active Risedronte Placebo Teriparatide | 3 | 10 | 6 |
| other | Injection Site Irritation | Skin and subcutaneous tissue disorders | Placebo Risedronate Active Teriparatide, Active Risedronate | 1 | 9 | 1 |
| other | Difficulty Swallowing | Gastrointestinal disorders | Active Risedronate Active Teriparatide | 0 | 10 | 0 |
| other | Difficulty Swallowing | Gastrointestinal disorders | Active Risedronte Placebo Teriparatide | 1 | 10 | 1 |
| other | Difficulty Swallowing | Gastrointestinal disorders | Placebo Risedronate Active Teriparatide, Active Risedronate | 0 | 9 | 0 |
| other | Leg Cramping | Musculoskeletal and connective tissue disorders | Active Risedronate Active Teriparatide | 1 | 10 | 1 |
| other | Leg Cramping | Musculoskeletal and connective tissue disorders | Active Risedronte Placebo Teriparatide | 1 | 10 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01611571/events